Seow, C H <br/><br/>
Trough serum infliximab: a predictive factor of clinical outcome for infliximab treatment in acute ulcerative colitis.  [electronic resource] 

 -  Gut  Jan 2010 
 - 49-54 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1468-3288 
<br/><br/><label>Standard No.: </label>10.1136/gut.2009.183095  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adolescent<br/>Adult<br/>Aged<br/>Antibodies, Monoclonal--blood<br/>Antibody Formation<br/>Cohort Studies<br/>Colectomy<br/>Colitis, Ulcerative--blood<br/>Colonoscopy<br/>Drug Administration Schedule<br/>Drug Monitoring--methods<br/>Female<br/>Gastrointestinal Agents--blood<br/>Humans<br/>Infliximab<br/>Male<br/>Middle Aged<br/>Prognosis<br/>Remission Induction<br/>Risk Assessment--methods<br/>Treatment Outcome<br/>Young Adult